Grants for Nonprofits - Federal

The FY24 OCRP Clinical Trial Translational Endpoints Research Award intends to support correlation of clinical trial-related data (e.g., biosample analysis, imaging, or epidemiological data) with clinical outcomes or responses to therapies. Correlative studies may be associated with a past, ongoing, or future clinical trial in order to associate various factors (genetic, DOD FY24 Ovarian Cancer Clinical Trial Translational Endpoints Research Award 4biochemical, environmental and others) with initiation, progression, metastasis, recurrence, prognosis, diagnosis or effect of intervention on ovarian cancer outcomes. The translational research should address high-impact or unmet needs in ovarian cancer. The proposed research may be hypothesis testing or may be designed to generate new hypotheses to be tested in follow-up clinical research. The award may not be used to directly support a clinical trial.

The Administration for Children and Families (ACF) is funding a cooperative agreement to sponsor the Child Development Research Fellowship that gives child development professionals from across the national academic research community the opportunity to experience policy research relevant to programs serving low-income children and families. This award is for an organization to lead the Child Development Research Fellowship Program. The organization must be a Professional Membership Organization for researchers who can support the Child Development Research Fellowship Program. A Professional Membership Organization aims to support individuals professionally and aid them in progressing within their career/profession. The goal of the fellowship program is to expose researchers to policy environments, particularly at the federal level, whereby they gain skills and expertise for policy-relevant research. The program is intended to stimulate the fellows knowledge of child development research and evaluation, particularly regarding services for low-income children and families, and to inform their process of developing long-term, policy-relevant research and evaluation agendas. The public will benefit from the increased availability of researchers highly skilled and experienced in policy and program relevant research and evaluation. Fellows will engage on a full-time basis for a period of 1 year (with a possible second or third year at the discretion of the award recipient and depending on funding availability). Fellows will be exposed to the broader child development policy environment, particularly at the federal level, and to the policy research community through activities organized and conducted by the award recipient. Fellows will learn extensively about ACF and our programs that serve young children and their families. The cooperative agreement will require active partnership between the successful applicant and Office of Planning, Research and Evaluation (OPRE).For more information about OPRE, see http://www.acf.hhs.gov/opre . Please subscribe to this forecast at grants.gov to receive notification of any updates.

This program provides funding to support training and resources for educators and rehabilitation professionals to improve braille literacy and nonvisual technology access for individuals who are blind.

The USAID funded Libya EVER Activity is a new five-year activity whose goal is to improve the effectiveness of key Libyan institutions and build the capacity of a diverse set of Libyan actors to advance the democratic political transition, including national and local elections, and support a stronger more inclusive democratic culture in Libya. The Libya EVER Activity (The Activity) has two main objectives: Objective 1: Strengthen Libyas election institutions and government stakeholders to carry out credible electoral and political processes at the local and national levels Objective 2: Empower the diversity of Libyas citizens and civil society to advance the democratic process in Libya.

The Office of Refugee Resettlement (ORR), within the Administration for Children and Families (ACF), announces the availability of funds for the National Refugee Leadership and Lived Experience Council (NRLLEC) Program. The NRLLEC is a new program funded by the Office of Refugee Resettlement (ORR) that designs, implements, evaluates, and promotes national-level councils consisting of refugees and other ORR-eligible populations who have resettled into communities throughout the United States within the last five years. The NRLLEC Program will facilitate a National Young Adult Leadership Council comprised of members ages 18 to 24 every year for three years, as well as two additional councils with thematic focus to be determined in consultation with ORR. The NRLLEC Program will design, implement, evaluate, and promote five councils during the three-year project period. The programs primary goal is to positively impact the lives of council members and their refugee and larger communities by building council members capacity to serve as leaders. In addition, ORR recognizes that its engagement with these groups will enhance its ability to gather information from individual members firsthand about their lived experiences integrating into the United States. This will help inform ORR and its recipient network about how to best meet refugee needs through enhancing or changing ORR guidance, programming, and future councils. The NRLLEC Program will foster inclusivity, with council members attuned to the diversity, demographics, needs, and viewpoints of ORRs eligible population (https://www.acf.hhs.gov/orr/programs/refugees/factsheets). The NRLLEC Program will not seek consensus advice from council members.

This funding opportunity is designed to establish a center that will coordinate and advance research on whole person health by integrating diverse biomedical knowledge and fostering collaboration among researchers.

This funding opportunity supports researchers with active NCI U01 awards who want to integrate innovative cancer research technologies to improve their studies and advance cancer prevention, detection, diagnosis, and treatment.

The grant titled "Score-2025-01" is a funding opportunity announced by the U.S. Small Business Administration to support the SCORE program, which offers mentoring and education to small business owners and entrepreneurs across the U.S., and applications must be submitted electronically with all necessary documents and registrations.

This funding opportunity supports research to uncover genetic factors related to mental disorders in diverse populations, particularly those of non-European ancestry, while promoting community engagement and career development for early-career researchers.

Allergic reactions to drugs and vaccines are a serious public health concern. For the purpose of this notice of funding opportunity (NOFO), allergic reactions include not only IgE-mediated reactions, but other immune-mediated and largely unpredictable drug and vaccine reactions. Based on data from 2013-2014, each year in the United States there are an estimated 200,000 emergency department visits for adverse events related to antibiotics. In children 5 or younger, antibiotics cause more than half (56%) of estimated emergency department visits for adverse drug events and 82% of these visits are due to allergic reactions. Allergic reactions to antibiotics include immediate life-threatening reactions such as anaphylaxis, severe cutaneous reactions including Toxic Epidermal Necrolysis and Drug Reaction with Eosinophilia and Systemic Symptoms, and less severe reactions that still limit further use of the drugs. A label of antibiotic allergy leads to the use of alternative, frequently more expensive antibiotics, often with lower efficacy, which may contribute to antibiotic resistance as well as increased mortality and morbidity in hospitalized patients. While allergic reactions to vaccines are less common, the inability to receive a vaccine due to an allergy is problematic to the individual, and the perceived risk of allergic reactions to vaccines contributes to vaccine hesitancy creating a public health issue. Objectives The objective of this NOFO is to solicit innovative projects to study the mechanisms and management of vaccine or antibiotic drug allergy (research on allergic responses to anti-viral, anti-fungal and anti-parasitic drugs will also be considered). The scope of research into antibiotic or vaccine allergic reactions includes, but is not limited to, the following: IgE-mediated and other mechanisms of immediate allergic antibiotic or vaccine reactions Non-IgE-mediated urticarial reactions to antibiotics or vaccines Delayed-type hypersensitivity reactions to antibiotics or vaccines Severe cutaneous adverse antibiotic or vaccine reactions Biomarkers to identify people at risk for reaction or to confirm reactions to specific antibiotics or vaccines Host factors that may predispose to allergic reactions including, but not limited to, host microbiome, genetics, or inflammatory conditions Mechanisms by which specific infections may increase the risk of an allergic reaction to an antibiotic or vaccine Immunomodulatory approaches to treating or preventing immunologic adverse antibiotic or vaccine reactions A secondary objective of this NOFO is to expand the number of investigators working in the field of vaccine and antibiotic drug allergy. Early-stage investigators are encouraged to apply. UG3/UH3 phase transition and Milestones This funding opportunity is designed as a two-stage cooperative agreement in which Project Scientists from NIAID will work with the investigative team. It will support projects that are organized into a two-year UG3 phase followed by a three-year UH3 phase. The UG3 phase may include pilot, observational, or hypothesis-generating high-risk projects. Preliminary data may be helpful but are not required. The use of electronic health records to identify potential participants for mechanistic studies is allowed. The use of human samples such as those related to clinically indicated and routinely used interventions or tests is encouraged. The UG3 must include milestones to determine the success of the project at the end of this phase. Milestones may be negotiated or re-negotiated after award as this program includes the flexibility to quickly revise milestones and/or aims within the scope of the original peer-reviewed application. Following the completion of the UG3 phase, NIAID staff will review the progress made and make the determination on whether the project will continue to the UH3 phase. NIAID support for the UH3 is contingent upon progress made during the UG3 phase, meeting the milestones, programmatic priorities, the original UG3/UH3 peer review recommendations, and the availability of funds. Some projects might not transition from the UG3 to the UH3 phase. Projects supported by the UH3 phase are required to be hypothesis driven, mechanistic, and extend the work initiated by the UG3 phase. Program Director/Principal Investigator (PD/PI) Meeting Attendance A kick-off meeting and annual meetings will be organized by NIAID to facilitate interactions among recipients to share approaches, data, and methods, with the aim of developing a cadre of dedicated researchers to conduct antibiotic and vaccine allergy and advance mechanistic research. These meetings will convene yearly in the Rockville, Maryland area and will be held in person, though a virtual component will be available to allow broader participation from laboratory members. The PD/PI from each award is expected to attend the kickoff meeting and annual meetings in person. Applications that propose the following topics will be considered non-responsive and will not be reviewed: Adverse drug reactions that are predictable and/or related to pharmacologic properties of the drug such as toxicity or overdose Investigation into drugs that are not antibiotics or vaccines (however research on anti-viral, anti-fungal and anti-parasitic drugs is allowed) Investigations into Guillain-Barré Syndrome or drug-induced autoimmune reactions Investigations of central nervous system and other neurologic adverse responses Investigations into the pathogens rather than host allergic responses to the antibiotics or vaccines Applications that do not propose mechanistic research in the UH3 phase Vaccines that are administered via a route that is not the same route of administration as approved by the FDA Vaccines that are used as an immunotherapeutic (e.g. allergen immunotherapy) HIV/AIDS research

This grant provides funding to organizations focused on improving the humanitarian data ecosystem by developing workforce skills and establishing data technology standards to enhance crisis response efforts.

This funding opportunity provides a portion of the annual catch limit of Atlantic sea scallops to various eligible organizations and individuals for research projects that enhance scientific understanding and management of the scallop fishery.

The DoD Kidney Cancer, Clinical Trial Award is a funding opportunity aimed at supporting the implementation of clinical trials that have the potential to significantly impact the treatment or management of kidney cancer, with a focus on new products, pharmacologic agents, devices, clinical guidance, and emerging approaches and technologies.

This funding opportunity supports collaborative research teams of diverse experts to tackle ambitious challenges in dental, oral, and craniofacial science, focusing on innovative solutions like non-opioid pain therapies and health disparity-reducing technologies.

This funding opportunity supports researchers in developing innovative tools to measure human behavior and synchronize these measurements with brain activity, aiming to advance our understanding of brain-behavior relationships and improve interventions for neurobehavioral conditions.

This funding opportunity provides financial support to Native American Tribes, Alaska Native Villages, and nonprofit organizations serving Native Hawaiians to enhance their museum services and cultural preservation efforts.

This initiative provides $52.5 million in cash awards to teams developing innovative technologies for capturing carbon dioxide from the atmosphere, with a focus on promoting environmental equity and community benefits.

This program provides funding for initiatives that foster cultural, educational, and professional exchanges between the United States and Bahrain, targeting non-profit organizations, academic institutions, and individuals with a strong U.S. connection.

This funding opportunity provides financial support to a variety of organizations to help strengthen Botswana's health data systems and public health responses to HIV, tuberculosis, and other health threats.

The U.S. Mission Sweden Public Diplomacy Section (PDS) is pleased to announce that funding is available through its Public Diplomacy Grants Program. This is an Annual Program Statement, outlining our funding priorities, the strategic themes we focus on, and the procedures for submitting requests for funding. This notice is subject to availability of funding. Deadline for Applications: Applications for this Notice of Funding Opportunity will be reviewed on a rolling-basis with the following schedule: December 31, 2023: results to be advised the last week of January 2024 (estimated); March 31, 2024: results to be advised last week of April 2024 (estimated); June 30, 2024: results to be advised last week of August 2024 (estimated) Priority Program Areas in Sweden: SECURITY Programs that support or promote regional issues such as, but not limited to: regional security, cybersecurity, combatting trans-national crime, responding to global health crises, combatting malign influence, multilateral cooperation, enhancing stability in the region, and a rules-based order. SUSTAINABILITY Programs that support or promote sustainable economic ties and regional environmental issues such as, but not limited to: climate change mitigation, food security, biodiversity sustainability, blue/green technology, youth engagement, entrepreneurship and innovation, and cooperation on Arctic issues, including engaging indigenous communities. INCLUSION Programs that support inclusion, understanding, and integration such as, but not limited to: promoting diversity, equality, inclusion and accessibility, supporting underrepresented communities, promoting human rights, promoting mutual understanding across communities, supporting shared democratic values, and combatting mis- and disinformation. UNDERSTANDING Programs that deepen connections between the United States and Swedish communities such as, but not limited to; expanding understanding of U.S. policies, culture, and values to Swedish and regional audiences, supporting or promoting cross-cultural ties, and education and exchange opportunities. All programs must include a link to the United States and/or an element that builds understanding of the United States including, but not limited to U.S. policy, people, culture and/or perspectives. Examples of PDS Grants Program projects include, but are not limited to: Academic and professional lectures, seminars, and speaker programs; Artistic and cultural workshops, joint performances, and exhibitions; or Professional and academic exchanges and projects. The Embassy encourages the submission of unique and creative proposals from a wide variety of sources. Applicants may be not-for-profit organizations/associations, including think tanks and civil society/non-governmental organizations; educational institutions; individuals; and foreign public entities. For-profit or commercial entities are not eligible to apply. HOW TO APPLY: To apply for a grant, please fill out and e-mail us the SF-424 application form for individuals or organizations as well as theGrant Request Document(PDF 81 KB) and theU.S. Embassy Grant Budget Document(PDF 75 KB). Please note that in some cases you might get an error message when you try to open these PDF forms through your web browser. To access the PDF, right click on the link and save the document to your computer, then click Enable all features. This should then give you the option to open the document in Adobe reader. Application Forms SF-424A for individuals(PDF 162 KB) SF-424A for organizations(PDF 92.3 KB) SF-424BAssurances(PDF 64.2 KB) andInstructions(PDF 135 KB) SF-424ABudget Information(PDF 131 KB) Submission Criteria All applications must be submitted electronically [email protected] the deadline. All proposals must be complete and submitted in English. All applications must have a detailed budget. Budget amounts should be in USD. Applicants must confirm their nonprofit status. Evaluation Criteria (for more detailed information see the application review information section below): Preference will be given to institutions and individuals with a proven track record of executing superior events, workshops, and programs. Applications should have a U.S. component. Projects which incorporate one of our priority areas are often considered stronger. Please note that Embassy grants CANNOT be used to: fund religious or partisan political activity; fundraising campaigns; charitable activities; humanitarian aid; commercial projects; individual academic research; construction projects; projects whose primary aim is the institutional development and operational costs of the organization; lobbying for specific legislation or projects; scientific research; and projects seeking funds for personal use. The Embassy also cannot give grants to commercial firms/ for-profit firms. No entity listed on the Excluded Parties List System in the System for Award Management (SAM) is eligible for any assistance or can participate in any activities under an award in accordance with the OMB guidelines at 2 CFR 180 that implement Executive Orders 12549 (3 CFR 1986 Comp., p. 189) and 12689 (3 CFR1989 Comp., p. 235), Debarment and Suspension. If an organizations Statement of Interest (SOI) / application proposal is approved, a valid Unique Entity Identified (UEI) number, formerly referred to as a DUNS (Data Universal Numbering System) number, and an active SAM.gov registration will need to be obtained before an organization is able to receive final grant approval and funding. Individuals are not required to have a UEI (DUNS) number or be registered inSAM.gov. Multiple requests from the same applicant will be considered. Applicants should be aware that the total amount granted to any one organization will be considered when additional applications are considered. Cost sharing is not required although encouraged. Applications may be submitted for consideration at any time before the closing date of June 30, 2024. No applications will be accepted after that date. FEDERAL AWARD ADMINISTRATION INFORMATION Federal Award Information This notice is subject to availability of funding. Length of performance period: Up to 24 months Number of awards anticipated: Number of awards issued will be dependent on requested amounts for funding Award amounts: Awards may range from a minimum of $500.00 to a maximum of $75,000.00 (estimated) Total available funding: $200,000 (subject to availability) Type of Funding: Fiscal Year 2024 Public Diplomacy Funding Anticipated project start date: From January 1, 2024 Funding Instrument Type: Grants, Fixed Amount Awards, Awards to Individuals or Cooperative agreement. Cooperative agreements are different from federal awards in which PDS staff are more actively involved in the grant implementation. Project Performance Period: Proposed projects should be completed in 2 years or less. PDS will entertain applications for continuation grants funded under these awards beyond the initial budget period on a non-competitive basis subject to availability of funds, satisfactory progress of the program, and a determination that continued funding would be in the best interest of the U.S. Department of State. Authorizing legislation, type and year of funding: Funding authority rests in the Smith-Mundt act. The source of funding is FY2024 Public Diplomacy Funding. Application Review Information Each application will be evaluated and rated on the basis of the evaluation criteria outlined below. The criteria listed are closely related and are considered as a whole in judging the overall quality of an application. Organizational capacity and record on previous grants: The organization has expertise in its stated field and PDS is confident of its ability to undertake the project. This includes a financial management system and a bank account. Quality and Feasibility of the Program Idea The program idea is well developed, with detail about how project activities will be carried out. The SOI includes a reasonable implementation timeline. Goals and objectives: Goals and objectives are clearly stated and project approach is likely to provide maximum impact in achieving the proposed results. Priority Areas: Applicant has clearly described how stated goals are related to and support U.S. Embassy Swedens priority areas or target audiences. Budget: The budget justification is detailed. Costs are reasonable in relation to the proposed activities and anticipated results. The budget is realistic, accounting for all necessary expenses to achieve proposed activities. Monitoring and evaluation plan: Applicant demonstrates it is able to measure program success against key indicators and provides milestones to indicate progress toward goals outlined in the SOI. The project includes output and outcome indicators, and shows how and when those will be measured. Sustainability: Project activities will continue to have positive impact after the end of the project. A grants review panel will evaluate all eligible applications. Simplified Acquisition Threshold For any Federal award under a notice of funding opportunity, if the Federal awarding agency anticipates that the total Federal share will be greater than the simplified acquisition threshold on any Federal award under a notice of funding opportunity may include, over the period of performance (see 200.88 Simplified Acquisition Threshold), this section must also inform applicants: i. That the Federal awarding agency, prior to making a Federal award with a total amount of Federal share greater than the simplified acquisition threshold, is required to review and consider any information about the applicant that is in the designated integrity and performance system accessible through SAM (currently FAPIIS) (see 41 U.S.C. 2313); ii. That an applicant, at its option, may review information in the designated integrity and performance systems accessible through SAM and comment on any information about itself that a Federal awarding agency previously entered and is currently in the designated integrity and performance system accessible through SAM; iii. That the Federal awarding agency will consider any comments by the applicant, in addition to the other information in the designated integrity and performance system, in making a judgment about the applicant's integrity, business ethics, and record of performance under Federal awards when completing the review of risk posed by applicants as described in 200.205 Federal awarding agency review of risk posed by applicants. Anticipated Announcement and Federal Award Dates: Applications will be received and evaluated on as per the schedule given earlier in this Notice, beginning November 15, 2023 until the deadline for applications on June 30, 2024. Unsuccessful applicants will be notified within 30 business days of the grants review panel meetings to be held per the schedule given earlier in this Notice. Applicants selected for further consideration will be contacted within 30 days and asked to submit all remaining mandatory documents. Applicants should endeavor to submit their applications at least three months prior to the proposed projects start date. Please note we do not accept ongoing projects. Federal Award Notices The assistance award or cooperative agreement will be written, signed, awarded, and administered by the Grants Officer. The assistance award agreement is the authorizing document, and it will be provided to the recipient for review and signature by email. The recipient may only start incurring project expenses beginning on the start date of Period of Performance shown on the federal award document signed by the Grants Officer. If a SOI is selected for funding, the Department of State has no obligation to provide any additional future funding. Renewal of an award to increase funding or extend the period of performance is at the discretion of the Department of State. Issuance of this notice does not constitute an award commitment on the part of the U.S. government, nor does it commit the U.S. government to pay for costs incurred in the preparation and submission of proposals. Further, the U.S. government reserves the right to reject any or all proposals received. Payment Method: Payments will be made in installments, as needed to carry out the project activities. Administrative and National Policy Requirements: Terms and Conditions: Before submitting an application, applicants should review all the terms and conditions and required certifications which will apply to this award, to ensure that they will be able to comply. These include: 2 CFR 200, 2 CFR 600, Certifications and Assurances, and the Department of State Standard Terms and Conditions, all of which are available here (PDF) . Note the U.S representation, flag branding and marking requirements in the Standard Terms and Conditions. Reporting Requirements: Recipients will be required to submit financial reports and program reports. The award document will specify how often these reports must be submitted. Federal Awarding Agency Contacts: If you have any questions about the federal award application process, please contact PDS at: [email protected] Note: We do not provide any pre-consultation for application related questions that are addressed in this announcement. Once an application has been submitted, State Department officials and staff both in the Department and at embassies / missions overseas may not discuss this competition with applicants until the entire proposal review process is completed.